Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Breast cancer patients taking CDK4/6 inhibitors are more likely to experience fatigue, hair loss, and mouth sores.

The new ddPCR method reliably detects unwanted viruses in CAR-T cell products, ensuring their safety for patients.

A 15-year-old boy's severe scalp condition improved significantly with adalimumab and baricitinib treatment.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Isotretinoin is recommended for acne treatment as it is as effective as cyproterone compound.

Acitretin treats severe skin conditions but requires careful monitoring due to serious side effects.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

Extended-release divalproex is better tolerated and more effective for seizures and psychiatric symptoms than delayed-release divalproex, but doesn't reduce hair loss.

Ribonucleotide excision repair is crucial to prevent skin cancer.

Some side effects of breast cancer chemotherapy last longer than others, and patient feedback can help improve care.

TRASER effectively targets blood vessels and hair follicles for potential use in vascular and hair removal treatments.

Cepharanthine and tetrandrine show promise as COVID-19 drugs.

Upadacitinib may effectively treat alopecia areata without side effects.

Exercise-induced particles can slow breast cancer growth by boosting immune response.

Trametinib can effectively treat severe kaposiform lymphangiomatosis when other treatments fail.

Ribonucleotide excision repair is crucial to prevent skin cancer.

Taking vitamin C and vitamin E twice a day can help prevent sunburn and DNA damage from UVB exposure.

Targeted protein degraders show promise in treating cancer but need to target more diverse proteins.

A Korean woman with complete hair loss regrew her hair after taking tofacitinib, with no side effects.

Tridax procumbens extracts can harm cell division and increase cell death in onion roots.

Tirzepatide improved symptoms and hair regrowth in a man with folliculitis decalvans.

Continuous baricitinib is needed to keep hair regrowth in severe alopecia areata.

Tofacitinib improved hair and nail conditions in a teen with alopecia areata.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

TCDD changes skin cell growth and keratin production in mice.

PPX causes much less hair loss than traditional taxanes.

Erlotinib can cause persistent excessive hair growth.